Analyze Diet
The Veterinary record1979; 105(2); 26-30; doi: 10.1136/vr.105.2.26

Phenylbutazone toxicity in ponies.

Abstract: The oral administration of phenylbutazone at a dose rate of approximately 10 mg per kg per day for seven to 14 days resulted in the development of signs of toxicity in seven of eight ponies treated. Clinical signs included anorexia, depression and abdominal oedema. Blood biochemical determinations showed a decrease in total plasma protein and calcium concentrations with an increase in urea concentration. These changes were considered indicative of water retention. Three of the ponies died during treatment following the development of shock. Shock was considered to arise from the submucosal oedema of the large intestine observed on necropsy. Oral ulceration was also found in these animals. In two ponies intravenous administration of phenylbutazone (4.0 mg per kg) for seven days was studied. In one of these ponies a marked decrease in total plasma protein concentration occurred.
Publication Date: 1979-07-14 PubMed ID: 555115DOI: 10.1136/vr.105.2.26Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper discusses the consequences of the toxicity of phenylbutazone, a drug, given orally at about 10 mg/kg/day for 1-2 weeks in ponies, with symptoms like anorexia, depression, and abdominal swelling. Notably, blood biochemistry revealed a drop in total plasma protein and calcium but a rise in urea quantities. Three ponies succumbed to shock resulting from large intestine submucosal edema, and were also found with oral ulcers. In an examination of two ponies given phenylbutazone intravenously at 4.0 mg/kg for a week, a notable decline in total plasma protein was seen in one.

Phenylbutazone Toxicity in Ponies

  • The study focuses on phenylbutazone toxicity in ponies. This drug, given to the ponies orally at a dosage rate of approximately 10 mg per kg per day for a period between seven to 14 days, led to observable effects of toxicity in seven of the eight ponies treated.
  • Common symptoms of this toxicity included anorexia (loss of appetite), a state of depression, and abdominal oedema (accumulation of fluid in the abdominal cavity, causing swelling).

Changes in Blood Biochemical Determinants

  • Following the administration of phenylbutazone, changes in blood biochemical determinants were noted where total plasma protein and calcium concentrations decreased significantly.
  • An increase in urea concentration was also observed. Such changes hinted at water retention in the body of the ponies, which is unhealthy and can lead to severe medical conditions.

Mortality and Necropsy Findings

  • Interestingly, death occurred in three of the ponies during the treatment, following the development of shock. This shock was attributed to submucosal oedema of the large intestine, as discovered during necropsy (examination after death).
  • Apart from the intestinal oedema, oral ulceration was found in these ponies. That alludes to the damaging effects of the phenylbutazone drug when given in high doses.

Effects of Intravenous Administration of Phenylbutazone

  • The research also considered the effects of administering phenylbutazone intravenously: a method that introduces the drug directly into the bloodstream, thus skipping the digestion process.
  • The dosage given was 4.0 mg per kg, for seven days. In one of the two ponies administered this way, a significant decrease in total plasma protein concentration was observed. This indicates the adverse effects phenylbutazone might have on blood health, regardless of the mode of administration.

Cite This Article

APA
Snow DH, Bogan JA, Douglas TA, Thompson H. (1979). Phenylbutazone toxicity in ponies. Vet Rec, 105(2), 26-30. https://doi.org/10.1136/vr.105.2.26

Publication

ISSN: 0042-4900
NlmUniqueID: 0031164
Country: England
Language: English
Volume: 105
Issue: 2
Pages: 26-30

Researcher Affiliations

Snow, D H
    Bogan, J A
      Douglas, T A
        Thompson, H

          MeSH Terms

          • Administration, Oral
          • Animals
          • Horse Diseases / chemically induced
          • Horse Diseases / pathology
          • Horses
          • Injections, Intravenous
          • Intestines / pathology
          • Phenylbutazone / administration & dosage
          • Phenylbutazone / toxicity
          • Stomach / pathology
          • Tongue / pathology

          Citations

          This article has been cited 4 times.
          1. Mozaffari AA, Derakhshanfar A. Evaluation of the brain, renal, and hepatic effects of flunixin meglumine, ketoprofen, and phenylbutazone administration in Iranian fat-tailed sheep. Trop Anim Health Prod 2011 Oct;43(7):1389-93.
            doi: 10.1007/s11250-011-9866-5pubmed: 21503752google scholar: lookup
          2. Geor RJ, Petrie L, Papich MG, Rousseaux C. The protective effects of sucralfate and ranitidine in foals experimentally intoxicated with phenylbutazone. Can J Vet Res 1989 Apr;53(2):231-8.
            pubmed: 2713788
          3. Carrick JB, Papich MG, Middleton DM, Naylor JM, Townsend HG. Clinical and pathological effects of flunixin meglumine administration to neonatal foals. Can J Vet Res 1989 Apr;53(2):195-201.
            pubmed: 2713784
          4. Ellison RS, Jacobs RM. The isoelectric focusing properties of serum alkaline phosphatase in disease and following prednisolone and phenylbutazone administration in the horse. Can J Vet Res 1990 Jan;54(1):126-31.
            pubmed: 2306661